ChemicalBook
English   Japanese   Germany   Korea

1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼

1-(嘧啶-2-基)-3A
1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼
CAS号:
303153-00-6
英文名:
4,5-BIS(HYDROXYMETHYL)-3-HYDRAZIDO-4,5-DIHYDROISOXAZOLE-1-(2-PYRIMIDYL)PIPERID-4-ONE ACETAL
英文别名:
4,5-BIS(HYDROXYMETHYL)-3-HYDRAZIDO-4,5-DIHYDROISOXAZOLE-1-(2-PYRIMIDYL)PIPERID-4-ONE ACETAL;1'-(pyrimidin-2-yl)-3a,4,8,8a-tetrahydrospiro[[1,3]dioxepino[5,6-d][1,2]oxazole-6,4'-piperidine]-3-carbohydrazide;1-(Pyrimidin-2-yl)-3a',4',8',8a'-tetrahydrospiro[piperidine-4,6'-[1,3]dioxepino[5,6-d]isoxazole]-3'-carbohydrazide;Spiro[[1,3]dioxepino[5,6-d]isoxazole-6,4'-piperidine]-3-carboxylic acid, 3a,4,8,8a-tetrahydro-1'-(2-pyrimidinyl)-, hydrazide
中文名:
1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼
中文别名:
1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼
CBNumber:
CB1664007
分子式:
C15H20N6O4
分子量:
348.36
MOL File:
Mol file

1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼化学性质

安全信息

1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼性质、用途与生产工艺

1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼 上下游产品信息

上游原料

下游产品


1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼 生产厂家

供应商联系电话电子邮件国家产品数优势度
南京世洲生物科技有限公司 025-85560043 13675144456 sean.lv@synzest.com 中国 11442 58
 

303153-00-6, 1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼 相关搜索:

  • 1-(嘧啶-2-基)-3A',4',8',8A'-四氢螺[哌啶-4,6'-[1,3]二氧杂卓并[5,6-D]异噁唑]-3'-甲酰肼
  • 303153-00-6
  • 1-(Pyrimidin-2-yl)-3a',4',8',8a'-tetrahydrospiro[piperidine-4,6'-[1,3]dioxepino[5,6-d]isoxazole]-3'-carbohydrazide
  • Spiro[[1,3]dioxepino[5,6-d]isoxazole-6,4'-piperidine]-3-carboxylic acid, 3a,4,8,8a-tetrahydro-1'-(2-pyrimidinyl)-, hydrazide
  • 1'-(pyrimidin-2-yl)-3a,4,8,8a-tetrahydrospiro[[1,3]dioxepino[5,6-d][1,2]oxazole-6,4'-piperidine]-3-carbohydrazide
  • 4,5-BIS(HYDROXYMETHYL)-3-HYDRAZIDO-4,5-DIHYDROISOXAZOLE-1-(2-PYRIMIDYL)PIPERID-4-ONE ACETAL
Copyright 2016 © ChemicalBook. All rights reserved